This information was published on 2026-01-29T07:36:51 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2615982 (IR 1895009) |
| (220) |
08 Sep 2025
|
| (300) |
US, 08 Aug 2025, 99327824
|
| (511) (510) |
Class 5
Pharmaceutical preparations; pharmaceutical preparations for the treatment of cystic fibrosis; pharmaceutical preparations for the treatment of genetic diseases or disorders; pharmaceutical preparations for the treatment of endocrine diseases or disorders; pharmaceutical preparations for the treatment of cellular diseases or disorders; pharmaceutical preparations for the treatment of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disorders. Class 42 Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing of pharmaceuticals; consulting services for others in the field of pharmaceutical research and development; consulting services for others in the field of pharmaceuticals research; research and development in the field of cystic fibrosis; research and development in the field of genetic diseases or disorders; research and development in the field of endocrine diseases or disorders; research and development in the field of cellular diseases or disorders; research and development in the field of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disorders. |
| (540) | SIONNA |
| (550) | Word |
| (730) |
Sionna Therapeutics, Inc.
|
Find out more about publications on the About page.